Who owns MONOPAR THERAPEUTICS INC?
- Ticker: MNPR
- CUSIP Number: 61023l207
Tip: Access positions for across all investors
Analyze quarterly positions in Monopar Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Monopar Therapeutics stock
Who bought or sold MONOPAR THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Henderson Group | 1.3M | $105M | 13% | Sep 2025 |
|
| Adage Capital Partners GP | 659k | $54M | 10% | Sep 2025 |
|
| RA Capital Management | 511k | $42M | 0% | Sep 2025 |
|
| Wellington Management Company | 232k | $19M | 100% | Sep 2025 |
|
| Vanguard Group | 208k | $17M | 141% | Sep 2025 |
|
| BlackRock | 204k | $17M | -1% | Sep 2025 |
|
| Deerfield Management Company | 160k | $13M | 100% | Sep 2025 |
|
| Saturn V Capital Management | 155k | $13M | 100% | Sep 2025 |
|
| TCG Crossover Management | 153k | $13M | 100% | Sep 2025 |
|
| ADAR1 Capital Management | 130k | $11M | 29% | Sep 2025 |
|
| Vivo Capital | 91k | $7.4M | 100% | Sep 2025 |
|
| Geode Capital Management | 85k | $6.9M | -12% | Sep 2025 |
|
| Affinity Asset Advisors | 80k | $6.5M | 18% | Sep 2025 |
|
| State Street Corporation | 72k | $5.9M | 73% | Sep 2025 |
|
| Driehaus Capital Management | 65k | $5.3M | 100% | Sep 2025 |
|
| Ally Bridge Group | 65k | $5.3M | 87% | Sep 2025 |
|
| Northern Trust | 27k | $2.2M | -16% | Sep 2025 |
|
| Bank of New York Mellon | 17k | $1.4M | 92% | Sep 2025 |
|
| Barclays | 15k | $1.2M | 107% | Sep 2025 |
|
| Eudaimonia Asset Management | 15k | $1.2M | 100% | Sep 2025 |
|
| Alyeska Investment Group | 12k | $998k | 100% | Sep 2025 |
|
| Charles Schwab Investment Management | 12k | $964k | -11% | Sep 2025 |
|
| UBS Group | 8.0k | $651k | -64% | Sep 2025 |
|
| Morgan Stanley | 7.9k | $284k | 100% | Jun 2025 |
|
| Millennium Management | 7.3k | $599k | -50% | Sep 2025 |
|
| Goldman Sachs Group | 6.5k | $533k | -65% | Sep 2025 |
|
| Gerber | 5.6k | $457k | 0% | Sep 2025 |
|
| Rhumbline Advisers | 5.3k | $432k | -10% | Sep 2025 |
|
| Susquehanna International | 4.3k | $354k | -48% | Sep 2025 |
|
| Nuveen | 4.2k | $345k | 100% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 4.0k | $328k | 19% | Sep 2025 |
|
| Florida State Board of Administration | 3.5k | $287k | 100% | Sep 2025 |
|
| MetLife Investment Advisors | 2.5k | $207k | 0% | Sep 2025 |
|
| Wells Fargo & Company | 2.3k | $190k | 1% | Sep 2025 |
|
| Quest Partners | 1.9k | $158k | 8% | Sep 2025 |
|
| Mirae Asset Global Etfs Holdings | 1.6k | $133k | -27% | Sep 2025 |
|
| Jpmorgan Chase & Co | 1.5k | $122k | 1391% | Sep 2025 |
|
| New York State Common Retirement Fund | 1.2k | $98k | -59% | Sep 2025 |
|
| Police & Firemen's Retirement System of New Jersey | 964.00 | $79k | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 696.00 | $57k | 101% | Sep 2025 |
|
| Goss Wealth Management | 600.00 | $49k | 0% | Sep 2025 |
|
| Tower Research Capital | 552.00 | $45k | 100% | Sep 2025 |
|
| Legal & General Group | 377.00 | $31k | -17% | Sep 2025 |
|
| FMR | 350.00 | $29k | 1029% | Sep 2025 |
|
| Russell Investments | 337.00 | $28k | 100% | Sep 2025 |
|
| Summit Investment Advisors | 300.00 | $25k | -28% | Sep 2025 |
|
| California State Teachers Retirement System | 255.00 | $21k | 0% | Sep 2025 |
|
| Amalgamated Bank | 139.00 | $11k | 0% | Sep 2025 |
|
| Hanson McClain Advisors | 100.00 | $8.2k | 0% | Sep 2025 |
|
| Royal Bank of Canada | 75.00 | $5.2k | 295% | Sep 2025 |
|
| SRS Capital Advisors | 14.00 | $1.1k | 100% | Sep 2025 |
|
| GAMMA Investing | 11.00 | $898.000400 | 100% | Sep 2025 |
|
| Sterling Capital Management | 9.00 | $735.000300 | -10% | Sep 2025 |
|
| CWM | 5.00 | $0 | 100% | Sep 2025 |
|
Who sold out of Monopar Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Point72 Asset Management | Jun 2025 | 104k | $3.7M |
| Citadel Advisors | Jun 2025 | 6.2k | $223k |
| Raymond James Financial | Jun 2025 | 431.00 | $15k |